Ascendis Pharma A/S (ASND)
Ascendis Pharma Market Cap : 18.09B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 18.09B |
| November 12, 2026 | 17.54B |
| November 11, 2026 | 17.03B |
| November 10, 2026 | 16.85B |
| November 09, 2026 | 17.07B |
| November 06, 2026 | 16.87B |
| November 05, 2026 | 16.64B |
| November 04, 2026 | 16.94B |
| November 03, 2026 | 16.43B |
| November 02, 2026 | 16.35B |
| October 30, 2026 | 16.50B |
| October 29, 2026 | 16.62B |
| October 28, 2026 | 16.39B |
| October 27, 2026 | 16.15B |
| October 26, 2026 | 16.10B |
| October 23, 2026 | 15.98B |
| October 22, 2026 | 15.96B |
| October 21, 2026 | 15.69B |
| October 20, 2026 | 15.39B |
| October 19, 2026 | 15.10B |
| October 16, 2026 | 14.79B |
| October 15, 2026 | 14.88B |
| October 14, 2026 | 14.91B |
| October 13, 2026 | 14.66B |
| October 12, 2026 | 14.91B |
| Date | Value |
|---|---|
| October 09, 2026 | 15.05B |
| October 08, 2026 | 14.62B |
| October 07, 2026 | 15.00B |
| October 06, 2026 | 14.85B |
| October 05, 2026 | 14.98B |
| October 02, 2026 | 14.96B |
| October 01, 2026 | 14.93B |
| September 30, 2026 | 14.96B |
| September 29, 2026 | 14.98B |
| September 28, 2026 | 15.11B |
| September 25, 2026 | 14.82B |
| September 24, 2026 | 15.15B |
| September 23, 2026 | 14.65B |
| September 22, 2026 | 15.60B |
| September 21, 2026 | 15.60B |
| September 18, 2026 | 15.55B |
| September 17, 2026 | 15.70B |
| September 16, 2026 | 16.27B |
| September 15, 2026 | 15.75B |
| September 14, 2026 | 17.40B |
| September 11, 2026 | 17.31B |
| September 10, 2026 | 17.16B |
| September 09, 2026 | 17.13B |
| September 08, 2026 | 17.74B |
| September 04, 2026 | 17.77B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| BioMarin Pharmaceutical, Inc. | 11.08B |
| Novo Nordisk A/S | 139.29B |
| Genmab A/S | 31.59B |
| Zealand Pharma A/S | 2.478B |
| Evaxion AS | 22.85M |
Market Cap Related Metrics
| PE Ratio | 17.73 |
| PS Ratio | 12.96 |
| Price to Book Value | 10.60 |
| Price to Free Cash Flow | 30.27 |
| Price | 275.39 |
| Earnings Yield | 5.64% |
| Operating PE Ratio | 70.59 |
| Normalized PE Ratio | 17.73 |